0
Original Research: PULMONARY HYPERTENSION |

Incidence of Chronic Thromboembolic Pulmonary Hypertension After a First Episode of Pulmonary Embolism*

Cecilia Becattini, MD; Giancarlo Agnelli, MD; Raffaele Pesavento, MD; Mauro Silingardi, MD; Renzo Poggio, MD; Maria Rita Taliani, MD; Walter Ageno, MD
Author and Funding Information

Affiliations: *From the Dipartimento di Medicina Interna (Drs. Becattini, Agnelli, and Taliani), Medicina Interna e Cardiovascolare, Università di Perugia, Perugia, Italy; Dipartimento di Scienze Mediche e Chirurgiche (Dr. Pesavento), Cattedra di Clinica Medica II, Università di Padova, Padua, Italy; Divisione di Medicina Interna I (Dr. Silingardi), Arcispedale S Maria Nuova, Reggio Emilia, Italy; II Divisione Medicina Generale-Centro Trombosi (Dr. Poggio), Ospedale Galliera, Genoa, Italy; and the Dipartimento di Medicina Interna e Terapia Medica (Dr. Ageno), Università dell’Insubria, Varese, Italy.,  A list of other investigators and sites involved in the study is located in the Appendix.

Correspondence to: Cecilia Becattini, MD, Sezione di Medicina Interna e Cardiovascolare, Dipartimento di Medicina Interna, Università di Perugia, Via G. Dottori, Ospedale Silvestrini, 06129 Perugia, Italy; e-mail: agnellig@unipg.it



Chest. 2006;130(1):172-175. doi:10.1378/chest.130.1.172
Text Size: A A A
Published online

Study objective: To assess the incidence of chronic thromboembolic pulmonary hypertension (CTPH) after the first episode of objectively confirmed pulmonary embolism (PE).

Design: Prospective cohort study in 12 Italian medical centers.

Patients: Consecutive patients treated with oral anticoagulants for the first episode of PE, either idiopathic or associated with temporary risk factors, were followed up for at least 3 years. Patients were excluded from the study if they had a known persistent risk factor for venous thromboembolism (VTE).

Interventions: At the follow-up visits, patients were evaluated for persistent dyspnea, either at rest or on exertion. All patients who were referred with dyspnea were assessed by transthoracic echocardiography, with evaluation of the systolic and mean pulmonary artery pressures. Patients with evidence of pulmonary hypertension on echocardiography underwent perfusion lung scans and pulmonary angiography to confirm the diagnosis of CTPH.

Results: Overall, 259 patients were included in the study. PE was idiopathic in 135 patients, while it was associated with at least a temporary risk factor for VTE in 124 patients. After an average follow-up period of 46 months, 37 patients were found to have persistent dyspnea that was unexplained in 5 patients. Among these patients, a diagnosis of CTPH was confirmed in two patients with idiopathic PE (0.8% of the overall study population [95% confidence interval (CI), 0.0 to 1.9]; 1.5% of patients with idiopathic PE [95% CI, 0.0 to 3.6]). The diagnosis was made 14 and 22 months, respectively, after the acute PE.

Conclusions: The incidence of CTPH observed in this study was about 1%. CTPH was observed in two patients with idiopathic PE.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543